Figure 2From: Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer Breast cancer specific survival by Kaplan-Meier analysis. Overall, the patients with GASC1 immunopositive tumors have better survival than the patients with GASC1 negative tumors (p=0.017 Log Rank; p=0.012, Breslow; p=0.013, Tarone-Ware).Back to article page